Holen Sie sich die Stockscreener-App
7.15
48.96%
2.35
Handel nachbörslich:
7.22
0.07
+0.98%
Schlusskurs vom Vortag:
$4.80
Offen:
$4.99
24-Stunden-Volumen:
58.81M
Relative Volume:
7.04
Marktkapitalisierung:
$1.65B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.80M
KGV:
-20.43
EPS:
-0.35
Netto-Cashflow:
$-68.07M
1W Leistung:
+45.03%
1M Leistung:
+109.68%
6M Leistung:
+210.87%
1J Leistung:
+176.06%
1-Tages-Spanne:
$4.94
$7.35
1-Wochen-Bereich:
$4.53
$7.35
52-Wochen-Spanne:
$1.54
$7.35
Nuvation Bio Inc Stock (NUVB) Company Profile
Firmenname
Nuvation Bio Inc
Sektor
Branche
Telefon
(415) 754-3517
Adresse
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Vergleichen Sie NUVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
7.15 | 1.65B | 0 | -75.80M | -68.07M | -0.35 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
ONC
Beone Medicines Ltd Adr
|
353.79 | 40.27B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Jefferies | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-03-08 | Eingeleitet | BTIG Research | Buy |
| 2021-03-08 | Eingeleitet | Cowen | Outperform |
| 2021-03-08 | Eingeleitet | Jefferies | Buy |
| 2021-03-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Nuvation Bio Shines On Breakthroughs And Analyst Upgrades - Finimize
How Nuvation Bio Inc. Class stock performs in easing cyclesJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Nuvation Bio stock initiated with Buy at B. Riley (NUVB:NYSE) - Seeking Alpha
Nuvation Bio (NUVB) Stock: Two Analysts Predict Major Upside on Promising Cancer Drug - parameter.io
Nuvation Bio stock hits 52-week high at $5.57 - Investing.com
Nuvation Bio stock hits 52-week high at $5.57 By Investing.com - Investing.com Australia
B. Riley Initiates Coverage on Nuvation Bio With Buy Rating, $12 Price Target - MarketScreener
Is Nuvation Bio Inc. stock overvalued by current metricsShare Buyback & Step-by-Step Trade Execution Guides - newser.com
What is the fair value estimate for Nuvation Bio Inc. Warrants stock in 2025Share Buyback & Growth Focused Stock Reports - newser.com
How big funds are accumulating Nuvation Bio Inc. Class stockWeekly Investment Summary & Fast Moving Trade Plans - newser.com
How Nuvation Bio Inc. stock performs in stagflationMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Nuvation Bio initiated with a Buy at B. Riley - TipRanks
Will Nuvation Bio Inc. Class stock draw ESG focused fundsPrice Action & Verified High Yield Trade Plans - newser.com
Is Nuvation Bio Inc. Warrants stock a defensive play amid uncertaintyQuarterly Performance Summary & Verified Stock Trade Ideas - newser.com
Is Nuvation Bio Inc. stock recession proofWeekly Risk Report & Trade Opportunity Analysis Reports - newser.com
Nuvation Bio stock initiated with Buy rating at B.Riley on strong Ibtrozi launch - Investing.com Australia
Can you recover from losses in Nuvation Bio Inc.July 2025 Levels & Weekly Momentum Stock Picks - newser.com
Will Nuvation Bio Inc. Class stock profit from AI boomJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
Will Nuvation Bio Inc. Warrants stock benefit from mergersTrade Volume Report & Growth Oriented Trade Recommendations - newser.com
Nuvation Bio Inc. (NUVB) is a Buy at H.C. Wainwright on Cancer Drug Development Progress - Finviz
What data driven models say about Nuvation Bio Inc.’s futureTrade Signal Summary & Real-Time Volume Triggers - newser.com
Published on: 2025-11-18 22:13:31 - newser.com
Is Nuvation Bio Inc. Class stock ideal for retirement investorsJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Is Nuvation Bio Inc. Warrants stock undervalued after correctionJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Nuvation Bio Reports Positive Phase 2 Study Results - TipRanks
Nuvation Bio Inc Publishes Positive Phase 2 Study Results for Safusidenib - TradingView
How Nuvation Bio Inc. stock reacts to inflationary pressuresTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
What candlestick patterns are forming on Nuvation Bio Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Will Nuvation Bio Inc. Warrants stock announce a stock splitGap Up & Weekly Market Pulse Updates - newser.com
Is Nuvation Bio Inc. stock reversal real or fake2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Will Nuvation Bio Inc. price bounce be sustainableJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Can Nuvation Bio Inc. stock maintain operating margins2025 Technical Patterns & Safe Entry Momentum Stock Tips - newser.com
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):